Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium
New Approaches to Neuroblastoma Therapy Consortium
Steven G DuBois; M Meaghan Granger; Susan Groshen; Denice Tsao-Wei; Lingyun Ji; Anasheh Shamirian; Scarlett Czarnecki; Fariba Goodarzian; Rachel Berkovich; Hiroyuki Shimada; Judith G Villablanca; Kieuhoa T Vo; Navin Pinto; Yael P Mosse; John M Maris; Suzanne Shusterman; Susan L Cohn; Kelly C Goldsmith; Brian Weiss; Gregory A Yanik; Clare J Twist; Meredith S Irwin; Daphne A Haas-Kogan; Julie R Park; Araz Marachelian; Katherine K Matthay